The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The molecular landscape of pembrolizumab and lenvatinib treatment in endometrial cancer.
 
Erica V. Carballo
No Relationships to Disclose
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Courtney A. Penn
No Relationships to Disclose
 
Kartik Angara
Employment - Caris Life Sciences
 
Premal H. Thaker
Stock and Other Ownership Interests - Immunon
Consulting or Advisory Role - AADi; AstraZeneca; Eisai; GlaxoSmithKline; Immunogen; Immunon; Iovance Biotherapeutics; Merck; Novocure; R-Pharm; Seagen; Verastem/Pharmacyclics; Zentalis
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Thomas J. Herzog
Leadership - GOG Foundation
Consulting or Advisory Role - Aadi; AstraZeneca; Caris MPI; Clovis Oncology; Corcept Therapeutics; Eisai; Epsilogen; GlaxoSmithKline; Johnson & Johnson; Merck; Mersana; Seagen
 
Kristen D. Starbuck
No Relationships to Disclose